Phase ii trial of uft in advanced colorectal and gastric cancer

British Journal of Cancer

Volumn 62, Issue 6, 1990, Pages 1023-1025

  Malik, S T A ^a   Talbot, D ^a   Clarke, P I ^a   Osborne, R ^a   Reznek, R ^b   Wrigley, P F M ^a   Slevin, M L ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TEGAFUR; URACIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MALE; METASTASIS; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH CANCER;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DRUG EVALUATION; FEMALE; HUMAN; MALE; MIDDLE AGE; STOMACH NEOPLASMS; TEGAFUR; URACIL;

EID: 0025604967     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1990.431     Document Type: Article

References (17)

1. ANSFIELD, F., KLOTZ, J., NEALON, T. & 6 others (1977). A phase III study comparing the clinical utility of four regimens of 5- fluorouracil. Cancer, 39, 34.
2. ANTTILA, M.I., SLOTANIEMI, E.A., KAIRALUOMA, M.I., MOKKA, R.E. & SUNDQUIST, H.T. (1983). Pharmacokinetics of Ftorafur after intravenous and oral administration. Cancer Chemother. Pharmacol., 10, 150.
3. AU, J.L., WU, A.F., FRIEDMAN, M.A. & SADEED, W. (1979). Pharmacokinetics and metabolism of Ftorafur in man. Cancer Treatment Rep., 63, 343.
4. BLOKHINA, N.G., VOSNY, E.K. & GARCIN, A M. (1972). Results of treatments of malignant tumours with Ftorafur. Cancer, 30, 390.
5. CHABNER, B.A. (1982). Pyrimidine antagonists In Pharmacological Principles of Cancer Treatment, Chabner, B.A. (ed.) p. 183. Saunders: Philadelphia.
6. DREWINKO, B. & YANG, L.Y. (1985). Cellular basis for the inefficacy of 5-FU in human colon carcinoma. Cancer Treat. Rep., 69, 1391.
7. EARL, H.M., COOMBES, R.C. & SCHEIN, D.S. (1984). Cytotoxic chemotherapy for cancer of the stomach. Clin. Oncol., 3, 351.
8. ERLICHMAN, C., FINE, S., WONG, A. & ELHAKIM, T. (1988). A randomised trial of fluorouracil with folinic acid in patients with metastatic colorectal carcinoma. J. Clin. Oncol., 6, 469.
9. FUJII, S., IKENAKA, K., FUKUSHIMA, M. & SHIRASAKA, T. (1978). Effect of uracil and its derivatives on antitumour activity of 5-fluorouracil and l-(2-tetrahydrofuryl)-5-fluorouracil. Gann, 69, 763.
10. FUJII, S., KITANO, S., IKENAKA, K. & SHIRASAKA, T. (1979). Effect of co-administration of uracil or cytosine on the antitumour activity of clinical doses of l-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents. Gann, 70, 209.
11. FUJII, S., SHIRASAKA, T., IKENAKA, K. & KITANO, S. (1980). Effect of uracil on antitumour activity of 1-(2-tetrahydrofuryl)-5-fluor- ouracil. Current Chemotherapy and Infectious Disease: Proceedings of the 11th ICC and the 19th ICAAC, p. 1529.
12. LOKICH, J.J., AHLGREN, J.D., GULLO, J.J., PHILLIPS, J.A. & FRYER, J.G. (1989). A prospective randomised trial of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. J. Clin. Oncol., 7, 425.
13. MOERTEL, C.G. (1973). Large bowel. In Cancer Medicine, Holland, J.F. & Frei, E. Ill (eds) p. 1597. Lea and Febiger: Philadelphia.
14. TAGUCHI, T., FURUE, H., KOYAMA, Y. & 4 others (1990). Phase I study of UFT. Cancer Chemother. (in the press).
15. TAGUCHI, T., NAKANO, Y., JIKUYA, K. & 4 others (1978). Determination of 5-fluorouracil levels in tumours, blood and other tissues. Cancer Chemother., 5, 1167.
16. WADLER, S., SCHWARTZ, E.L., GOLDMAN, M. & 6 others (1989). Fluorouracil and recombinant alpha-2a-interferon: an active regimen against advanced colorectal carcinoma. J. Clin. Oncol., 7, 1769.
17. WHO (1979). Handbook for Reporting Results of Cancer Treatment. Offset Publication no. 48, p. 22. WHO: Geneva.